This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Cardiosonic Ltd.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Jonathan Yalom in Renal Denervation
Introduction
Jonathan Yalom is an accomplished inventor based in Gedera, Israel. He has made significant contributions to the field of medical technology, particularly in the area of renal denervation. His innovative work focuses on devices and methods that enhance the effectiveness of renal sympathetic denervation treatments.
Latest Patents
Jonathan Yalom holds a patent for "Devices and methods for renal denervation and assessment thereof." This invention relates to devices and methods for intravascular denervation and assessment, specifically targeting renal denervation. The patent describes an intravascular catheter designed for ultrasonic ablation of tissue, which includes a plurality of piezoelectric transceivers. Additionally, the invention features an intravascular distancing device that ensures a minimal distance between an ultrasound emitting element and the tissue, such as the blood vessel wall. The patent also addresses the assessment of renal sympathetic denervation (RSD) treatment effectiveness by processing echo signals to characterize the physical and mechanical properties of blood vessels.
Career Highlights
Jonathan Yalom is associated with Cardiosonic Ltd., a company that focuses on developing advanced medical technologies. His work at Cardiosonic Ltd. has been instrumental in pushing the boundaries of renal denervation techniques.
Collaborations
He has collaborated with notable colleagues, including Ariel Sverdlik and Or Shabtay, to further enhance the development of innovative medical devices.
Conclusion
Jonathan Yalom's contributions to renal denervation technology exemplify the impact of innovation in the medical field. His patent and work at Cardiosonic Ltd. highlight the importance of advancing treatment methods for improved patient outcomes.